Read + Share
Amedeo Smart
Independent Medical Education
Wester A, Shang Y, Toresson Grip E, Matthews AA, et al. Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 2024;73:835-843.PMID: 38253482
Email
LinkedIn
Facebook
Twitter
Privacy Policy